facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
6/2022
vol. 109
 
Share:
Share:
abstract:
Case report

Acute generalized exanthematous pustulosis in temporal association with COVID-19 vaccine

Simay Bayrak Ozturk
1
,
Melike Ordu
2

  1. Department of Dermatology, Aksaray Training and Research Hospital, Aksaray University, Aksaray, Turkey
  2. Department of Pathology, Aksaray Training and Research Hospital, Aksaray University, Aksaray, Turkey
Dermatol Rev/Przegl Dermatol 2022, 109, 464-468
Online publish date: 2023/04/21
View full text Get citation
 
PlumX metrics:
Introduction:
Acute generalized exanthematous pustulosis is characterized by small, sterile, non-follicular, and sudden-onset pustular reactions on an erythematous surface. It typically involves intertriginous regions and the trunk and is usually accompanied by itching and a feeling of pain in the lesion areas. Often pharmacological treatments and frequent viral eruptions, including enterovirus, coxsackie, Epstein-Barr virus, and hepatitis B, play a role in the etiology of the disease.

Case report:
Here, we present the case of acute generalized exanthematous pustulosis in a 17-year-old young woman triggered by the 1st dose of COVID19 mRNA BioNTech vaccine.

Conclusions:
We are reporting a rare case of vaccine-related acute generalized exanthematous pustulosis, associated with a COVID-19 vaccination.

keywords:

acute generalized exanthematous pustulosis, BioNTech, COVID19 vaccine, virus, treatment



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.